Digestive Cancers Europe - for Patients

Startpagina
België
Brussels
Digestive Cancers Europe - for Patients

DiCE is a European non-profit umbrella organisation of nearly 40 national Member Organisations across Europe.
(1)

14/11/2025

DiCE proudly supports SCAN 2025, a global survey by the International Neuroendocrine Cancer Alliance (INCA) exploring how people with neuroendocrine tumours (NETs) navigate their healthcare systems.

If you are a person living with NETs, a carer of someone with NETs or a healthcare professional, share your experience to raise awareness about barriers to diagnosis and treatment, and promote real change in access to care worldwide.

This is a follow-up to INCA’s first global survey in 2019, now repeated for a comparative analysis.

⏱️ Takes about 20 minutes, is completely anonymous, collects no personal data and is available in 15 different languages.

👉 https://incalliance.org/scan2025/

NET Cancer Day

13/11/2025

Opera singer Luciano Pavarotti died in 2007 at age 71 from advanced pancreatic cancer. His passing shows how this illness can affect lives regardless of fame or legacy.

Did you know you can take action to lower your risk of pancreatic cancer?
Start today by learning the everyday choices that help keep your pancreas healthy.

Learn more: https://digestivecancers.eu/pancreatic-cancer-what/pancreatic-cancer-risk-prevention/

Pancreatic Cancer Action Network Pancreatic Cancer UK World Pancreatic Cancer Day

12/11/2025

𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝟔𝐭𝐡 𝐃𝐢𝐂𝐄 𝐂𝐑𝐂 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐒𝐮𝐦𝐦𝐢𝐭!
🗓️ 4 December 2025 at ⏰ 9:00 AM (CET)

This year’s summit will bring together leading experts, healthcare professionals, patients and policymakers to advance effective, accessible, and sustainable CRC screening programmes. Together, we aim to reduce inequalities, improve early diagnosis, and save more lives.

📹 Hear directly from DiCE CEO Zorana Maravic in a special video message on why this summit matters!

Register NOW👉 https://digestivecancers-eu.zoom.us/webinar/register/WN_nMNt2FFjSAq9zYs51fT51Q #/registration

Colorectal Cancer Alliance Colon Cancer Coalition Global Colon Cancer Association

11/11/2025

DiCE member organisation Fondation ARCAD, Aide et Recherche en CAncérologie Digestive is launching the A.R.CA.D 2026 Hackathon, Europe’s largest innovation weekend dedicated to digestive oncology, from March 27 to 29, 2026.

💡 Got an idea to improve screening, treatment, or patient care pathway? Whether it’s a sketch on a napkin or a ready concept, this is your chance to turn it into a real prototype with expert guidance, teamwork, and support.

🙌 Open to everyone: patients, students, healthcare professionals, innovators, and the simply curious.

🏆 Winners receive mentoring, visibility, and incubation opportunities to bring their ideas to life for a real impact that benefits patients.

👉 Submit your project now: https://or9ieqov0cb.typeform.com/to/XrGmaopf

fans EU Can Beat Cancer EU Science & Innovation EU Science Hub - Joint Research Centre

10/11/2025

Napoléon Bonaparte died in exile in 1821 at age 51; his autopsy concluded he died from gastric cancer.
A reminder that gastric cancer can affect anyone, regardless of power or position.

Because most countries don’t offer routine screening, it’s vital that people at higher risk know the warning signs. If you have a family history of gastric cancer or other risk factors, speak with your doctor to understand your risk and learn about early detection.

To know more, visit: https://digestivecancers.eu/gastric-oesophageal-cancer-prevention/

fans EU Can Beat Cancer EU Science & Innovation EU Science Hub - Joint Research Centre

07/11/2025

Yesterday, Zorana Maravic, CEO of Digestive Cancers Europe (DiCE), spoke at an important webinar on patents and access to medicines.

💊 The session explored how patent systems can create barriers to the medicines patients need, and equipped advocates with practical knowledge to navigate these complex challenges.

From understanding how patents influence the availability of medicine to learning advocacy strategies from industry experts and fellow advocates, this webinar provided a strong foundation for patient organisations to strengthen their impact.

A big thank you to all the speakers and participants who contributed to this important conversation on unlocking innovation and unblocking access to treatments.

Sandoz EU Science & Innovation European Patients' Forum European Patients' Academy on Therapeutic Innovation (EUPATI)

07/11/2025

#𝐆𝐥𝐨𝐛𝐚𝐥𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬𝐖𝐞𝐞𝐤 𝟐𝟎𝟐𝟓 𝐜𝐨𝐦𝐞𝐬 𝐭𝐨 𝐚𝐧 𝐞𝐧𝐝!

In the past days, we talked about how biosimilars have helped reshape healthcare by improving access to vital treatments, driving innovation, and saving billions that can be reinvested in better care. Yet, unequal access remains a major challenge in Europe and beyond.

To unlock their full potential, we must work together with policymakers and healthcare professionals to ensure consistent access across regions, strengthen trust through education and transparent communication, and build sustainable systems that truly benefit patients.

Learn more about biosimilars and their benefits: https://biosimilars.education.digestivecancers.eu/

06/11/2025

Patrick Swayze’s death at 57 reminds us of the toll pancreatic cancer takes and of the urgent need for greater awareness, earlier diagnosis, and better treatments.

In approximately 5–10% of cases, pancreatic cancer is linked to inherited genetic factors. That’s why knowing your risks is so important: awareness of family history and consultation with a healthcare professional can make a real difference.

Learn more about understanding your risk: https://digestivecancers.eu/pancreatic-cancer-what/pancreatic-cancer-risk-prevention/

Pancreatic Cancer UK Pancreatic Cancer Ireland Pancreatic Cancer Action Network POLA prieš vėžį

06/11/2025

✅ 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬 𝐚𝐫𝐞 𝐡𝐞𝐥𝐝 𝐭𝐨 𝐫𝐢𝐠𝐨𝐫𝐨𝐮𝐬 𝐬𝐚𝐟𝐞𝐭𝐲 𝐚𝐧𝐝 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬.

Before approval, each biosimilar undergoes a comprehensive scientific evaluation by the European Medicines Agency (EMA) to demonstrate equivalence with its reference medicine in quality, safety, and efficacy.

Like all medicines, biosimilars are closely monitored after approval. They are therefore considered a reliable part of modern healthcare, expanding treatment options in major areas of chronic disease, such as cancer, and contributing to improved health outcomes.

Learn more: https://globalbiosimilarsweek.org/2025/

05/11/2025

On 26 November, at 15 CET, join GUIDE.MRD Educational Webinar for Patients, a session co-created with patients and highlighting the “ideal healthcare pathway” and the factors that influence its adoption in clinical practice.

You'll learn how liquid biopsy and timely interventions can change lives, hearing directly from the experts behind the project.

🔗 Register Now: https://precisionmedicine.synapseconnect.org/events/peof-coffee-learn-pathways-for-early-detection-of-cancer-relapse-a-guide-mrd-educational-webinar-for-patients

GUIDE.MRD is an EU-funded project, of which DiCE is part, focusing on early detection of relapse after treatment through liquid biopsy.

fans

05/11/2025

💊 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬 𝐢𝐦𝐩𝐫𝐨𝐯𝐞 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐟𝐨𝐫 𝐚𝐜𝐜𝐞𝐬𝐬.

They enable more patients across Europe to benefit from essential treatments for cancer, diabetes, arthritis, and immune-related diseases.

Given that 70–80% of EU healthcare costs are associated with chronic conditions, biosimilars can support sustainability by facilitating broader access to treatment while alleviating pressures on healthcare systems. This can strengthen equity and contribute to the long-term sustainability of our healthcare systems.

Learn more: https://globalbiosimilarsweek.org/2025/

04/11/2025

From 28 October until 8 November, Niall Rochford, co-founder of Pancreatic Cancer Ireland, will walk 250 km from Cork to Cong in memory of his wife, Stella, who died from pancreatic cancer just eight weeks after her diagnosis. It is a 12-day route retracing key moments in Stella’s life.

Join Pancreatic Cancer Ireland in raising awareness and funds for urging earlier detection and faster diagnosis of one of Ireland’s deadliest cancers.

Take your own , and help spread the word, because every step counts.

👉 https://www.pancreaticcancerireland.ie/cork2cong

fans EU Can Beat Cancer Pancreatic Cancer Action Network Pancreatic Cancer UK World Pancreatic Cancer Day Ashford Castle in Ireland

Adres

Rue De La Loi 235
Brussels
1040

Website

https://digestivecancers.eu/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Digestive Cancers Europe - for Patients nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.